7d70c697-4f6d-465e-ab67-e461b11dc9f0.pdf (2.0 MB)
Really strong results
Topline up by 35%+
Bottomline up by 40%+
Pat margin came in at 13.6% vs 13.2% YOY
Another interesting development is the incorporation of 2 wholly-owned subsidiaries for Pharma business
Disclosure- No recommendations